Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cesar Virgen, M.D.

Concepts (143)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Cesar Virgen's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Cesar Virgen has written about over time.
Cytosine Deaminase, 1 publications between 2007 and 2007, average publication date October 2007. vif Gene Products, Human Immunodeficiency Virus, 1 publications between 2007 and 2007, average publication date October 2007. Cyclophilin A, 1 publications between 2008 and 2008, average publication date February 2008. Mutant Chimeric Proteins, 1 publications between 2008 and 2008, average publication date February 2008. Bacteria, 1 publications between 2018 and 2018, average publication date February 2018. Fungi, 1 publications between 2018 and 2018, average publication date February 2018. Paronychia, 1 publications between 2018 and 2018, average publication date February 2018. Skin Diseases, Bacterial, 2 publications between 2018 and 2020, average publication date April 2019. Skin, 2 publications between 2018 and 2020, average publication date September 2019. Gram-Negative Bacteria, 1 publications between 2020 and 2020, average publication date June 2020. Gram-Positive Bacteria, 1 publications between 2020 and 2020, average publication date June 2020. Lymphoma, T-Cell, 1 publications between 2023 and 2023, average publication date August 2023. Lymphoma, T-Cell, Peripheral, 1 publications between 2023 and 2023, average publication date August 2023. Myasthenia Gravis, 1 publications between 2023 and 2023, average publication date August 2023. Myocarditis, 1 publications between 2023 and 2023, average publication date August 2023. Myositis, 1 publications between 2023 and 2023, average publication date August 2023. Orthopoxvirus, 1 publications between 2024 and 2024, average publication date April 2024. Poxviridae Infections, 1 publications between 2024 and 2024, average publication date April 2024. Carcinoma, Squamous Cell, 1 publications between 2024 and 2024, average publication date May 2024. Vulvar Neoplasms, 1 publications between 2024 and 2024, average publication date May 2024.

To see the data from this visualization as text, click here.
Virgen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (143)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.